Barcelona Liver Bioservices presents novel microfluidic human liver slice model for antifibrotic drug screening at AASLD Meeting: GLP1-R agonist Liraglutide demonstrates antifibrotic activity
Washington DC, November 7th 2025 Barcelona Liver Bioservices (BLB), a leading preclinical research organization specialized in liver disease modeling and drug discovery, is proud to







